Announcements Trials
Browse Landscape

Phase

Phase 2 3Phase 3 2

Status

Completed 161Terminated 52Active not recruiting 5

Sponsor Class

OTHER 2INDUSTRY 2NIH 1

Study Type

Interventional 5

Sponsor

Cancer Type

Gastrointestinal 3Sarcoma 1Head & Neck 1Endocrine 1

Conditions

Carcinoma, Hepatocellular 2Thyroid cancer, Hurthle cell 1Neuroectodermal Tumors, Primitive, Peripheral 1Neoplasms 1Gastrointestinal Stromal Tumors 1Desmoplastic Small Round Cell Tumor 1Carcinoma 1

Interventions

pembrolizumab 84Specimen Handling 79Carboplatin 74Magnetic Resonance Spectroscopy 71Biopsy 58Nivolumab 55Cisplatin 55Paclitaxel 46Cyclophosphamide 44durvalumab 37Radiotherapy 36Radiation 35Rituximab 34olaparib 33Etoposide 33Dexamethasone 33Ipilimumab 30Gemcitabine 30Lenalidomide 28Taxes 27Pemetrexed 27Doxorubicin 27Docetaxel 27Bevacizumab 24Prednisone 23Cytarabine 23X-Rays 22Trastuzumab 21cabozantinib 20Disulfides 20

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
Active not recruiting × Has results × Sorafenib × Clear all
NCT00265798 2026-04-28

Sorafenib in Treating Patients With Malignant Gastrointestinal Stromal Tumor That Progressed During or After Previous Treatment With Imatinib Mesylate and Sunitinib Malate

National Cancer Institute (NCI)

Phase 2 Active not recruiting
38 enrolled 9 charts
GastrointestinalSarcoma

Gastrointestinal Stromal Tumors

NCT03298451 2026-03-20

HIMALAYA

AstraZeneca

Phase 3 Active not recruiting
1,324 enrolled 31 charts 1 FDA
Gastrointestinal

Carcinoma, Hepatocellular

NCT01946529 2026-02-23

Therapeutic Trial for Patients With Ewing Sarcoma Family of Tumor and Desmoplastic Small Round Cell Tumors

St. Jude Children's Research Hospital

Phase 2 Active not recruiting
24 enrolled 11 charts

Neuroectodermal Tumors, Primitive, Peripheral, Desmoplastic Small Round Cell Tumor

NCT02143726 2026-02-11

Sorafenib Tosylate With or Without Everolimus in Treating Patients With Advanced, Radioactive Iodine Refractory Hurthle Cell Thyroid Cancer

Alliance for Clinical Trials in Oncology

Phase 2 Active not recruiting
35 enrolled 14 charts
EndocrineHead & Neck

Thyroid cancer, Hurthle cell

NCT03755791 2025-12-11

COSMIC-312

Exelixis

Phase 3 Active not recruiting
837 enrolled 14 charts
Gastrointestinal

Carcinoma, Carcinoma, Hepatocellular, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡